Veillonella parvula is a tiny, Gram-negative anaerobic coccus that lives in the human mouth, gut, and upper respiratory tract, and its defining metabolic trick is that it cannot use sugars at all. Instead, it feeds almost exclusively on lactate and other organic acids produced by neighboring bacteria, making it one of the most metabolically specialized members of the human microbiome. That unusual diet places V. parvula at the center of microbial food webs in dental plaque, gives it a complicated role in oral disease, and occasionally lets it cause serious infections when it escapes its normal habitat.
A Bacterium That Cannot Eat Sugar
Most bacteria you hear about in the context of human health are sugar fermenters. V. parvula is the opposite. It does not ferment glucose or any other carbohydrate. It is anaerobic, nonmotile, and arranges itself in pairs, short chains, or clumps. Early characterization work established that the genus Veillonella produces propionic acid, acetic acid, carbon dioxide, and hydrogen gas from lactate during growth, and that resting cells can also break down pyruvate, oxaloacetate, malate, fumarate, and succinate, but not citrate or isocitrate.1PubMed Central. THE GENUS VEILLONELLA. I. GENERAL CULTURAL, ECOLOGICAL, AND BIOCHEMICAL CONSIDERATIONS That profile makes V. parvula obligately dependent on other microbes for its primary carbon source. It is, in effect, a scavenger living off the metabolic waste of its neighbors.
This dependence is especially clear in the mouth. V. parvula is considered a “bridging species” in oral biofilms because its growth depends on lactate produced by oral streptococci.2PubMed Central. Identification of Veillonella parvula and Streptococcus gordonii adhesins mediating co-aggregation and its impact on physiology and mixed biofilm structure Without streptococci or other lactic acid bacteria nearby, V. parvula struggles to establish itself. With them, it thrives and, in the process, removes lactate from its surroundings, which has downstream consequences for acidity and disease.
How Lactate Becomes Propionate
The central metabolic pathway in V. parvula converts lactate into a mixture of propionate and acetate. Quantitative studies of washed cells showed that for every 100 molecules of lactate consumed, roughly 66 end up as propionate, 40 as acetate, 40 as carbon dioxide, and 14 as hydrogen gas.3PubMed Central. Lactate metabolism by Veillonella parvula The process starts with an enzyme called malate-lactate transhydrogenase, which was recently identified at the molecular level for the first time. This enzyme catalyzes the initial step by transferring reducing equivalents between lactate and oxaloacetate, and phylogenetic analysis found 88 related genes across the genus Veillonella, confirming it is a conserved and central feature of how these bacteria make a living.4PubMed Central. Vpar_1595 encodes malate-lactate transhydrogenase: The first step in lactate metabolism within the genus Veillonella
The pathway branches depending on whether the carbon flows through succinate decarboxylation or through pyruvate. When V. parvula grows on malate, fermentation proceeds cleanly to acetate and propionate. When it grows on lactate, more acetate and more hydrogen gas accumulate. Researchers detected methylmalonyl-CoA decarboxylase and an ATP-dependent pyruvate carboxylase in cell extracts, but not the transcarboxylase enzyme used by some other propionate-producing bacteria, suggesting V. parvula uses a somewhat distinctive version of the propionate pathway.5PubMed. Energy conservation by succinate decarboxylation in Veillonella parvula In practical terms, the important takeaway is that V. parvula’s metabolism vacuums up lactate and converts it primarily into weaker acids, which has real consequences for the acidity of its local environment.
Nitrate Reduction and Its Role in Colonization
Beyond lactate fermentation, V. parvula has another metabolic capability that turns out to be clinically relevant: it reduces nitrate to nitrite. In oral Veillonella species, this nitrate reduction is directly coupled to lactate oxidation, meaning the bacterium uses nitrate as an electron acceptor while burning through lactate.6PubMed Central. Nitrite Production from Nitrate and Its Link with Lactate Metabolism in Oral Veillonella spp. In the mouth, this nitrate-to-nitrite conversion feeds into the human body’s nitric oxide cycle, which has implications for blood pressure regulation. Oral bacteria that reduce nitrate are thought to contribute meaningfully to systemic nitric oxide levels, though V. parvula’s specific contribution compared to other oral nitrate reducers is still being sorted out.
This same nitrate respiration pathway takes on a different significance in the gut. During intestinal inflammation, host tissues produce more nitrate as a byproduct of the immune response. A mouse model of colitis showed that V. parvula exploits this inflammation-derived nitrate to colonize the intestine more successfully. When researchers deleted the narG gene responsible for nitrate respiration, the mutant V. parvula colonized inflamed intestines far less effectively than the wild-type strain.7PubMed Central. Inflammation-associated nitrate facilitates ectopic colonization of oral bacterium Veillonella parvula in the intestine This suggests that V. parvula, normally a mouth-dwelling organism, can take advantage of gut inflammation to establish itself in a place it does not usually belong, a phenomenon called ectopic colonization. Whether this ectopic presence worsens the inflammation or is merely an opportunistic side effect remains an active question.
The Complicated Role in Dental Disease
V. parvula’s relationship with tooth decay is genuinely messy and sometimes seems contradictory. On one hand, by consuming lactate, V. parvula should theoretically make plaque less acidic, which would protect tooth enamel. And indeed, one in vitro study found that V. parvula did not alter pH dynamics when co-cultured with the cavity-causing bacterium Streptococcus mutans over a 120-hour period.8Archives of Oral Biology. Effect of Veillonella parvula on the physiological activity of Streptococcus mutans Another study even found that V. parvula decreased the acidification of S. mutans biofilms in artificial saliva.9PubMed Central. A Co-Association of Streptococcus mutans and Veillonella parvula/dispar in Root Caries Patients and In Vitro Biofilms
On the other hand, the same co-culture study found that when S. mutans and V. parvula grew together, sucrose-dependent biofilm mass increased by 50 to 150% compared to S. mutans alone, even though V. parvula by itself could not form biofilms at all.9PubMed Central. A Co-Association of Streptococcus mutans and Veillonella parvula/dispar in Root Caries Patients and In Vitro Biofilms More biofilm means more surface for acid-producing bacteria to cling to, which could ultimately promote decay even if V. parvula is locally reducing acidity. Clinical sampling confirmed the link: V. parvula and S. mutans were found together at significantly higher levels on diseased root surfaces.
Work in a rodent model pushed the picture further. Researchers found that V. parvula could not cause dental caries on its own, but when co-infected with S. mutans, it significantly worsened the progression, quantity, and severity of cavities.10PubMed Central. Veillonella parvula acts as a pathobiont promoting the biofilm virulence and cariogenicity of Streptococcus mutans in adult severe caries The term researchers use is “pathobiont,” meaning an organism that is normally harmless but becomes disease-promoting in the right context. V. parvula seems to remodel the spatial structure and metabolic activity of S. mutans biofilms in ways that amplify the damage S. mutans does, even though V. parvula itself is not producing acid.
Periodontal Disease and Subgingival Plaque
V. parvula is not limited to tooth surfaces. It is also the predominant Veillonella species found in subgingival plaque, the bacterial community that accumulates below the gum line.11PubMed. Diversity of Veillonella spp. from subgingival plaque by polyphasic approach In periodontitis, the chronic gum disease that can lead to tooth loss, V. parvula shows up in elevated numbers. Patients with chronic periodontitis who had pus-draining (suppurating) sites carried significantly higher counts of V. parvula in those sites compared to patients with aggressive periodontitis.12PubMed. Suppuration-associated bacteria in patients with chronic and aggressive periodontitis
A more recent study explored how V. parvula fits into the pathology of diabetes-associated periodontitis. Subgingival plaque from patients with both diabetes and periodontitis showed higher abundance of both the major periodontal pathogen Porphyromonas gingivalis and V. parvula.13PubMed Central. Epithelial Inflammatory iNOS-Nitrate Axis Enhances P. gingivalis Pathogenicity via V. parvula in Diabetes-Associated Periodontitis The proposed mechanism circles back to nitrate metabolism: inflamed gum tissue in diabetic patients produces more nitric oxide via the iNOS enzyme, which breaks down to nitrate, and V. parvula thrives on that nitrate. Its nitrate reduction then produces nitrite, which in turn may promote the growth of P. gingivalis. The pattern resembles what happens in the inflamed gut: V. parvula exploits inflammation-derived nitrate to establish itself and, in doing so, may worsen the overall microbial community’s pathogenic potential.
Rare Infections Beyond the Mouth
V. parvula normally minds its own business in the oral cavity and upper digestive tract. But when the mucosal barriers are breached or the immune system is weakened, it can show up in places where it has no business being. The infections it causes are rare but span a surprisingly wide range of body sites.
Endocarditis, infection of the heart valves, is the most dramatic. Case reports describe both native and prosthetic valve endocarditis caused by Veillonella species. One report documented a 76-year-old woman who presented with fever and was found to have a vegetation on her mitral valve; blood cultures grew Veillonella on day six of treatment.14PubMed Central. Native Valve Endocarditis due to Veillonella Species: A Case Report and Review of the Literature In another case, a 49-year-old man with a prosthetic valve developed acute heart failure from valve dehiscence caused by V. parvula, complicated by cortical blindness and limb weakness from cerebral embolism.15PubMed. Prosthetic valve endocarditis caused by Veillonella parvula
Spinal infections have also been reported. A 79-year-old man developed spondylodiscitis (infection of a vertebral disc) with an intramuscular abscess caused by V. parvula. He recovered fully after a course of intravenous ceftriaxone and metronidazole followed by oral amoxicillin-clavulanate.16PubMed Central. Spondylodiscitis due to anaerobic bacteria Veillonella parvula: Case report and literature review In a separate case, V. parvula caused lumbar discitis and secondary bacteremia, with researchers suspecting that an endoscopy and colonoscopy performed eight weeks earlier had allowed the organism to enter the bloodstream from the gut.17PubMed Central. Veillonella parvula discitis and secondary bacteremia: a rare infection complicating endoscopy and colonoscopy?
Lung infections are another site. Community-acquired lung abscesses commonly involve anaerobic oral bacteria after aspiration, and Veillonella has been isolated from both lung abscesses and cases of chronic pneumonitis.18PubMed Central. Veillonella Intrapulmonary Abscess With Empyema19PubMed. Veillonella as a cause of chronic anaerobic pneumonitis In fact, the link to aspiration is strong enough that a prospective study tested whether detecting Veillonella DNA in respiratory samples could help diagnose aspiration pneumonia. Veillonella species PCR achieved about 93% sensitivity and 97% specificity for aspiration pneumonia, substantially outperforming chest X-rays combined with symptoms.20PubMed Central. Utility of Veillonella parvula polymerase chain reaction in diagnosing aspiration pneumonia: a prospective observational study Finding V. parvula in the lungs is essentially a molecular fingerprint that oral bacteria have been aspirated into the lower airways.
Two common threads run through these case reports. First, most patients had some underlying vulnerability: advanced age, diabetes, prosthetic devices, or recent instrumentation of the gastrointestinal tract. A case of bacteremia from a decubitus ulcer infection in a patient with diabetes reinforced this pattern, and the V. parvula isolated was resistant to tazobactam-piperacillin, the empiric antibiotic initially chosen.21PubMed Central. Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula Second, outcomes are generally good when the organism is identified and appropriate antibiotics are selected. A review of two bacteremia cases found both isolates susceptible to most antibiotics, with successful outcomes.22PubMed. Bacteremia caused by Veillonella parvula: Two case reports and a review of the literature The challenge is getting the diagnosis right in the first place, since clinical labs often do not culture anaerobes routinely and empiric regimens may miss V. parvula.
Antibiotic Susceptibility and Diagnostic Challenges
V. parvula is susceptible to most antibiotics, but there is a notable exception: penicillin resistance appears to be common. A study testing 33 Veillonella strains from pediatric clinical samples found a significant rate of penicillin resistance, although other beta-lactam antibiotics retained their activity.23Anaerobe. Susceptibility of Veillonella spp. to Ten Different Antibiotics This matters because penicillin is a standard empiric choice for many infections where anaerobes might be involved. If V. parvula is the causative organism and penicillin resistance is present, initial treatment may fail, as was documented in the discitis case that did not respond to flucloxacillin.17PubMed Central. Veillonella parvula discitis and secondary bacteremia: a rare infection complicating endoscopy and colonoscopy? Broader-spectrum beta-lactams, metronidazole, and carbapenems generally remain effective, though the tazobactam-piperacillin-resistant case from a decubitus infection demonstrates that resistance profiles can surprise you.
Identifying Veillonella in the first place requires either an anaerobic culture setup or molecular methods. Many hospital labs do not routinely set up anaerobic cultures for every specimen, which means V. parvula infections can be missed or delayed. Modern mass spectrometry-based identification systems, such as MALDI-TOF, have improved the picture. An evaluation of one such system found that it correctly identified about 84% of anaerobic isolates to the species level, with clinically relevant and frequently isolated anaerobes performing well.24PubMed Central. Evaluation of VITEK mass spectrometry (MS), a matrix-assisted laser desorption ionization time-of-flight MS system for identification of anaerobic bacteria For difficult cases, 16S ribosomal RNA gene sequencing remains the gold standard for definitive identification. The broader point is that if a clinician does not suspect an anaerobe and does not request the right cultures, V. parvula will not be found, and the patient may cycle through ineffective antibiotics before the diagnosis is made.
The Athletic Performance Connection
One of the more unexpected chapters in the Veillonella story came from sports science. A 2019 study reported that marathon runners had increased relative abundance of Veillonella in their stool after a race. The researchers isolated a strain of a closely related species, Veillonella atypica, and inoculated it into mice. The mice ran significantly longer on a treadmill before reaching exhaustion. The mechanism? Serum lactate generated by exercise crosses the gut lining into the intestinal lumen, where Veillonella converts it to propionate. Rectal administration of propionate alone was enough to reproduce the improved run time, suggesting that the short-chain fatty acid propionate, rather than the removal of lactate, was driving the performance benefit.25PubMed Central. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism
This study used V. atypica rather than V. parvula, but the underlying metabolic logic applies across the genus. All Veillonella species share the core lactate-to-propionate pathway. The finding captured popular attention and spawned headlines about “performance-enhancing gut bugs,” though it is worth noting that this was demonstrated in mice. Whether supplementing humans with Veillonella would meaningfully improve athletic performance remains untested in controlled human trials. Still, the study elegantly illustrated how a bacterium’s unusual dietary preference, consuming an acid that most microbes ignore, can have measurable systemic effects on its host.
Exploring Plant-Based Approaches to Oral Biofilms
Because V. parvula’s partnership with S. mutans amplifies biofilm formation and dental disease, there is interest in disrupting that partnership. One research group tested an extract from guava leaves (Psidium guajava) against both S. mutans and V. parvula. The n-hexane fraction of the leaf extract showed antibacterial activity against both species and reduced the expression of gtfC, a gene S. mutans uses to build the sticky glucan matrix that holds biofilms together, in dual-species cultures.26PubMed Central. Psidium guajava Leaves n-Hexane Fraction Antibacterial Activity and the Inhibition of Gene Expression of gtfB and gtfC in the Combination Streptococcus mutans ATCC 25175 and Veillonella parvula ATCC 10790(T) This is still early-stage laboratory work, and it is a long road from showing an effect in a Petri dish to developing a mouthwash or dental product that safely and effectively disrupts these biofilms in a real mouth. But it reflects a broader trend in dental research toward targeting inter-species cooperation in plaque rather than trying to kill individual species one at a time. V. parvula’s role as a metabolic bridge between community members makes it an appealing target for that strategy.